A unique event dedicated to organoids
Organoids are Us 2025 brings together leading international experts – scientists, clinicians, and innovators – to discuss the latest advances in organoid research. This congress is a major platform to explore how these models can transform biomedical research, drug discovery, and personalized medicine.
Overcoming the challenges of organoid bioproduction
While organoids hold enormous promise, their adoption remains limited by technical barriers. Current production processes are expensive, complex, and lack scalability. These limitations not only slow down academic research but also delay the translation of organoid-based innovations into tangible solutions for patients.
Cellura’s contribution
At Cellura, we are addressing these bottlenecks with a proprietary bioreactor platform inspired by geo-mimicry.
-
Robust and scalable production of sensitive cells and fragile 3D models
-
Simplified processes accessible to both academic and industrial users
-
Significant reduction in production costs
Our goal is to enable researchers and biotech companies to fully unlock the potential of organoids without being constrained by bioproduction hurdles.
Building collaborations
We see Organoids are Us 2025 as an opportunity not only to share our work, but also to initiate collaborations with academic platforms, biotech innovators, and clinical experts. By working together, we can accelerate the transition from research to impact for patients.
Let’s meet at the congress
If you would like to arrange a discussion with our team during the event, please contact us at our short contact form.
We look forward to engaging with the community at Organoids are Us 2025 and contributing to the future of organoid-based therapies.
